CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.4210
+0.0050 (1.20%)
At close: Apr 27, 2026, 4:00 PM EDT
0.4100
-0.0110 (-2.61%)
After-hours: Apr 27, 2026, 4:00 PM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 39 employees as of December 31, 2025. The number of employees decreased by 18 or -31.58% compared to the previous year.
Employees
39
Change (1Y)
-18
Growth (1Y)
-31.58%
Revenue / Employee
$60,795
Profits / Employee
-$294,590
Market Cap
6.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | -18 | -31.58% |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 2 | 2.74% |
| Dec 31, 2022 | 73 | 7 | 10.61% |
| Dec 31, 2021 | 66 | 14 | 26.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| FibroBiologics | 15 |
| BioRestorative Therapies | 14 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Ernexa Therapeutics | 7 |
CLGN News
- 14 days ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 4 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 4 weeks ago - CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PRNewsWire
- 5 weeks ago - CollPlant Biotechnologies Launches Redesigned Corporate Website - PRNewsWire
- 6 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - PRNewsWire
- 2 months ago - CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - PRNewsWire
- 2 months ago - CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - PRNewsWire